Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.091

€0.091

-7.610%
-0.0075
-7.610%
-

-

 
08.05.24 / Frankfurt WKN: A0M8VQ / Name: E-Therapeutics / Stock / Biotechnology & Medical Research / Micro Cap /

E-Therapeutics Plc Stock

Heavy losses for E-Therapeutics Plc today as the stock fell by -€0.008 (-7.610%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for E-Therapeutics Plc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of E-Therapeutics Plc in the next few years

Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of E-Therapeutics Plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
E-Therapeutics Plc -7.610% - - - - - -
Proteome Sciences - 0.000% 0.000% 11.111% 6.667% -57.895% 185.714%
Oxford BioMedica PLC 2.660% 4.891% 73.874% -13.839% 58.197% -67.009% -50.000%
Evgen Pharma plc - 0.000% 0.000% -98.438% -80.000% -99.383% -

News

e-therapeutics plc shares now trading on JP Jenkins
e-therapeutics plc shares now trading on JP Jenkins
e-therapeutics plc shares now trading on JP Jenkins
Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery
Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery
Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery